Typhoid Conjugate Vaccine I.P.

Trade Name: BIOVAC
Available Strength : 0.5 ML
Available Combination : The Typhoid Conjugate Vaccine is used to protect against Typhoid fever caused by Salmonella typhi. In combination immunization programs, it can be administered alongside other routine vaccines to provide broader protection against multiple infectious diseases.
Packing : 0.5 ML PFS
Pack Insert/Leaflet : YES
Therapeutic use : The Typhoid Conjugate Vaccine is used to protect against Typhoid fever, a serious illness caused by contaminated food and water. It works by stimulating the body’s immune system to develop long-lasting protection against Salmonella typhi. The vaccine is recommended for children, adolescents, and adults, especially in areas where typhoid is common or during outbreaks.
Capacity : 1000

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.